Showing results (901-910 of 1,000) with videos related to

Sort By:
Pageof 100
Human Mutation|September 2, 2022
de novo variant calling identifies cancer mutation signatures in the 1000 Genomes ProjectJeffrey K Ng, Pankaj Vats, Elyn Fritz-Waters, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2025
Prognostic significance of individual COVADIS criteria in patients undergoing acetylcholine provocation testingRiccardo Rinaldi, Michele Russo, Ilaria Torre, et al.
Reviews in Cardiovascular Medicine|August 14, 2024
Age and Vasodilator Response to Different Hyperemic Agents: Adenosine versus Contrast MediumDomenico Galante, Stefano Migliaro, Federico Di Giusto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 25, 2023
Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized studyDomenico D'Amario, Mattia Galli, Attilio Restivo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
Journal of the American Heart Association|February 25, 2025
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation TestingRiccardo Rinaldi, Michele Russo, Giovanni Occhipinti, et al.
Minerva Cardiology and Angiology|February 27, 2023
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionRocco Vergallo, Marco Lombardi, Giorgos Besis, et al.
Molecular Therapy. Nucleic Acids|August 31, 2023
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonistsAssunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, et al.
Bone|April 25, 2017
Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRASMichael P Whyte, Malachi Griffith, Lee Trani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trialR Lesurf, O L Griffith, M Griffith, et al.
Pageof 100